Literature DB >> 17537219

Differentiation potential of urothelium from patients with benign bladder dysfunction.

Jennifer Southgate1, Claire L Varley, Mary A E Garthwaite, Jennifer Hinley, Fiona Marsh, Jens Stahlschmidt, Ludwik K Trejdosiewicz, Ian Eardley.   

Abstract

OBJECTIVE: To develop a novel in vitro approach to test the hypothesis that failure of urothelial differentiation underlies the aetiopathology of interstitial cystitis (IC), where there is evidence of compromised urinary barrier function, as benign dysfunctional bladder disease encompass several poorly understood clinically defined conditions, including IC, idiopathic detrusor overactivity (IDO) and stress urinary incontinence (SUI).
MATERIALS AND METHODS: Biopsy-derived urothelial cells from dysfunctional bladder biopsies were propagated as finite cell lines and examined for their capacity to differentiate in vitro, as assessed by the acquisition of a transitional cell morphology, a switch from a cytokeratin (CK)13(lo)/CK14(hi) to a CK13(hi)/CK14(lo) phenotype, expression of claudin 3, 4 and 5 proteins, and induction of uroplakin gene transcription.
RESULTS: Two of 12 SUI cell lines showed early senescent changes in culture and were not characterized further; one of seven IC, one of five IDO and a further three SUI cell lines had some evidence of senescence at passage 3. Of the seven IC-derived cell lines, four showed a near normal range of differentiation-associated responses, but the remainder showed little or no response. Most IDO cell lines (four of five) showed a normal differentiation response, but at least three of the 10 SUI cell lines showed some compromise of differentiation potential.
CONCLUSION: This study supports the existence of a subset of patients with IC in whom a failure of urothelial cytodifferentiation might contribute to the disease, and provides a novel platform for investigating the cell biology of urothelium from SUI and other benign dysfunctional conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537219      PMCID: PMC1961637          DOI: 10.1111/j.1464-410X.2007.06795.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  23 in total

Review 1.  Interstitial cystitis: a review of immunological aspects of the aetiology and pathogenesis, with a hypothesis.

Authors:  J P Van De Merwe; H J Arendsen
Journal:  BJU Int       Date:  2000-05       Impact factor: 5.588

2.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

3.  Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

Authors:  Punita Dhawan; Amar B Singh; Natasha G Deane; Yiran No; Sheng-Ru Shiou; Carl Schmidt; John Neff; M Kay Washington; R Daniel Beauchamp
Journal:  J Clin Invest       Date:  2005-06-16       Impact factor: 14.808

4.  A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis.

Authors:  R E Hurst; J B Roy; K W Min; R W Veltri; G Marley; K Patton; D L Shackelford; P Stein; C L Parsons
Journal:  Urology       Date:  1996-11       Impact factor: 2.649

5.  Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract.

Authors:  H E Schaafsma; F C Ramaekers; G N van Muijen; E C Ooms; D J Ruiter
Journal:  Histochemistry       Date:  1989

6.  KUH notes.

Authors:  G E Striker
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

7.  Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987.

Authors:  J Y Gillenwater; A J Wein
Journal:  J Urol       Date:  1988-07       Impact factor: 7.450

8.  Normal human urothelial cells in vitro: proliferation and induction of stratification.

Authors:  J Southgate; K A Hutton; D F Thomas; L K Trejdosiewicz
Journal:  Lab Invest       Date:  1994-10       Impact factor: 5.662

9.  Interstitial cystitis and pelvic floor dysfunction: a comprehensive review.

Authors:  J C Lukban; J V Parkin; A S Holzberg; R Caraballo; S Kellogg-Spadt; K E Whitmore
Journal:  Pain Med       Date:  2001-03       Impact factor: 3.750

10.  Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis.

Authors:  Gennady Slobodov; Michael Feloney; Christopher Gran; Kimberly D Kyker; Robert E Hurst; Daniel J Culkin
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450

View more
  24 in total

Review 1.  The Urothelium: Life in a Liquid Environment.

Authors:  Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Physiol Rev       Date:  2020-03-19       Impact factor: 37.312

2.  Krüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression.

Authors:  Huan He; Sheng Li; Yuan Hong; Haojing Zou; Hongyan Chen; Fang Ding; Yong Wan; Zhihua Liu
Journal:  J Biol Chem       Date:  2015-04-07       Impact factor: 5.157

3.  Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study.

Authors:  Davide De Vita; Salvatore Giordano
Journal:  Int Urogynecol J       Date:  2012-05-22       Impact factor: 2.894

4.  Normalization of proliferation and tight junction formation in bladder epithelial cells from patients with interstitial cystitis/painful bladder syndrome by d-proline and d-pipecolic acid derivatives of antiproliferative factor.

Authors:  Susan Keay; Piotr Kaczmarek; Chen-Ou Zhang; Kristopher Koch; Zoltan Szekely; Joseph J Barchi; Christopher Michejda
Journal:  Chem Biol Drug Des       Date:  2011-04-27       Impact factor: 2.817

5.  Structure-Activity Studies on Antiproliferative Factor (APF) Glycooctapeptide Derivatives.

Authors:  Piotr Kaczmarek; Gillian M Tocci; Susan K Keay; Kristie M Adams; Chen-Ou Zhang; Kristopher R Koch; David Grkovic; Li Guo; Christopher J Michejda; Joseph J Barchi
Journal:  ACS Med Chem Lett       Date:  2010-07-19       Impact factor: 4.345

6.  Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis.

Authors:  Davide De Vita; Henrik Antell; Salvatore Giordano
Journal:  Int Urogynecol J       Date:  2012-11-06       Impact factor: 2.894

7.  A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study.

Authors:  Susan Keay; Samantha Leitzell; Ashley Ochrzcin; George Clements; Min Zhan; David Johnson
Journal:  BMC Urol       Date:  2012-06-08       Impact factor: 2.264

8.  Aquaporin expression contributes to human transurothelial permeability in vitro and is modulated by NaCl.

Authors:  Peter C Rubenwolf; Nikolaos T Georgopoulos; Lisa A Kirkwood; Simon C Baker; Jennifer Southgate
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

9.  Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease.

Authors:  Hsin-Tzu Liu; Hann-Chorng Kuo
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

10.  Differentiation-associated reprogramming of the transforming growth factor β receptor pathway establishes the circuitry for epithelial autocrine/paracrine repair.

Authors:  Jonathan M Fleming; Saqib Shabir; Claire L Varley; Lisa A Kirkwood; Angela White; Julie Holder; Ludwik K Trejdosiewicz; Jennifer Southgate
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.